| ²é¿´: 581 | »Ø¸´: 2 | |||
1289622ľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Ò©Æ·±ê×¼ÖÐÈçºÎ¸ù¾Ý¸ø³öµÄÔÓÖʶÔÕÕÆ·µÄ±àºÅ²éѯËüµÄ½á¹¹Ê½µÈÐÅÏ¢£¿
|
|
¡¢Ò©Æ·±ê×¼ÖÐÈçºÎ¸ù¾Ý¸ø³öµÄÔÓÖʶÔÕÕÆ·µÄ±àºÅ²éѯËüµÄ½á¹¹Ê½µÈÐÅÏ¢£¿ ±ÈÈç·ÇÂåµØÆ½»ºÊÍÆ¬½ø¿Ú×¢²á±ê×¼ÖУ¬ÔÓÖÊΪ¡°Ñõ»¯²úÎH152/37£©¡±£¬ÈçºÎͨ¹ý¡°H152/37¡± Õâ¸ö±àºÅ²éµ½ËûµÄ½á¹¹Ê½µÈÆäËûÐÅÏ¢£¿ 2¡¢¡°H152/37¡±ÕâÑùµÄ±àºÅÊÇÔõôÀ´µÄ£¿Ó¦¸ÃÓÐרÃŵĹٷ½ÍøÕ¾ÊÕ¼ÕâЩ±ê׼Ʒ°É£¿ Çë²»Òª¸æËßÎÒH152/37Õâ¸öÎïÖÊÊÇʲô£¬Õâ¸öÎÒÖªµÀ¡£ ÎÒÏëÖªµÀµÄÊÇ£ºÔõÑùͨ¹ý¡°H152/37¡±ÕâÑùµÄ±àºÅÀ´²éѯÎïÖʵÄÏà¹ØÐÅÏ¢£¬ÓÐûÓйٷ½ÍøÕ¾ÊÕ¼£¬Òª²»È»Ôõô»¹»áÓÐÕâÑùµÄ±àºÅÄØ£¬¾ÍÏñCASºÅËÆµÄ£¬Í¨¹ýCASºÅ¾ÍÄܲé³ö¸ÃÎïÖʵÄϵÁÐÓйØÐÅÏ¢¡£ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
yiyaoziyuan |
» ²ÂÄãϲ»¶
070300»¯Ñ§354Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
286·Öµ÷¼Á
ÒѾÓÐ6È˻ظ´
287Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸Ö£´ó²ÄÁϹ¤³Ì290Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏ¿ÆÑ§Ó빤³Ìµ÷¼Á
ÒѾÓÐ4È˻ظ´
»¯Ñ§308·Öµ÷¼Á
ÒѾÓÐ8È˻ظ´
300Çóµ÷¼Á£¬²ÄÁÏ¿ÆÑ§Ó¢Ò»Êý¶þ
ÒѾÓÐ16È˻ظ´
085701Çóµ÷¼Á³õÊÔ286·Ö
ÒѾÓÐ5È˻ظ´
289Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
»¯Ò© ×ÔÖÆ¶ÔÕÕÆ·
ÒѾÓÐ11È˻ظ´
CDE¹²ÐÔÎÊÌâ½â´ð½â´ð20120725
ÒѾÓÐ26È˻ظ´
ÇëÎÊÊ²Ã´ÍøÕ¾¿ÉÒÔ²éѯҩƷ½á¹¹Ê½µÄ£¬Ð»Ð»ÁË
ÒѾÓÐ6È˻ظ´
´ó¼ÒÀ´ÌÖÂÛÒ»ÏÂÔõÑù»ñµÃÒ©ÎïÔÓÖʵĽṹʽÒÔ¼°¹ºÂòµÄ;¾¶
ÒѾÓÐ25È˻ظ´
¡¾Ô´´¡¿6Àà·ÂÖÆÒ©É걨ÏîÄ¿¼°×ÊÁÏÒªÇó
ÒѾÓÐ902È˻ظ´
qinghuoly
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 140 (¸ßÖÐÉú)
- ½ð±Ò: 4753.1
- ºì»¨: 10
- Ìû×Ó: 885
- ÔÚÏß: 918.1Сʱ
- ³æºÅ: 966225
- ×¢²á: 2010-03-09
- ÐÔ±ð: GG
- רҵ: ½ðÊôÓлú»¯Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
ÕâÖÖ±àºÅÒ»°ãÊÇΪÁ˱£ÃÜ£¬ËùÒÔÒ»°ã²é²»µ½¶ÔÓ¦µÄ½á¹¹¡£µ«ÓÐÒ»ÖÖ¶«Î÷½Ð½ø¿Ú×¢²á±ê×¼£¬ºÍ¸´ºË˵Ã÷£¬ÆäÖг£³£»áÓнṹʽ¡£ ¼¸ºõÎÞ·¨¹«¿ª²éµ½£¬µ«¿ÉÒÔµ½fda¡¢emeaµÄ¹«¿ªÎļþÖÐѰÕÒÏßË÷¡£ÕâЩÔÓÖÊÔÚÒ©Æ·¿ª·¢ÖбØÈ»ÒªÑо¿¶¾Àí¡¢ÏÞ¶È¡¢À´Ô´µÈµÈ¡£¾Ý´ËÍÆ²âÈ»ºóʵÑéÈ·ÈÏ¡£ µ±Ò»¸ö·ÂÖÆÒ©±»´ó¼Ò×öÀÃÁËʱ£¬ÆäÏàÓ¦µÄ±àºÅÔÓÖʾͻṫȻÔÚÍøÉÏÂô¡£Ò»°ãÖ¸¸ø±àºÅ£¬Ö»ÓйºÂò²Å»áÌṩÏàÓ¦µÄͼÆ×Êý¾ÝºÍ½á¹¹¡£µ«¹úÍâÓÐЩ±È½ÏºñµÀµÄÒ©ÎïÔÓÖÊÉÌ£¬±ÈÈçhttp://www.tlcpharmachem.com/tlc ... le_21&sub=T£¬ËÑË÷ÏàÓ¦µÄAPI£¬»á³öÏÖһϵÁл¯ºÏÎï¡£ÓÐʱ»áÔÚ±ðÃûÖÐʹÓÃÄÇЩ±àºÅ¡£ |

2Â¥2014-02-27 09:12:42
qinghuoly
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 140 (¸ßÖÐÉú)
- ½ð±Ò: 4753.1
- ºì»¨: 10
- Ìû×Ó: 885
- ÔÚÏß: 918.1Сʱ
- ³æºÅ: 966225
- ×¢²á: 2010-03-09
- ÐÔ±ð: GG
- רҵ: ½ðÊôÓлú»¯Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
ÒÔ·ÇÂåµØÆ½ÎªÀý¡£ÊÔ̽Ѱ Ñõ»¯²úÎH152/37£©µÄ½á¹¹¡£ ¸ù¾Ý·ÇÂåµØÆ½µÄ½á¹¹£¬¶þÇâßÁऻ·ºÜÈÝÒ×±»Ñõ»¯£¬¶ø·¼¹¹»¯ÎªßÁड£¶øÔÙÎÞÆäËûÒ×±»Ñõ»¯µÄ½á¹¹¡£×ãÒÔ¶ÏÑÔ´ËH152/37 Ϊ USP Felodipine Related Compound A RS Click to View Structure [ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate] (C18H17Cl2NO4 382.24) http://www.drugfuture.com/Pharma ... 0_alpha-19-817.html http://www.tlcpharmachem.com/tlc ... mp;li=&sub= µ±È»×Ðϸһµã¼ìË÷¿É¼ûרÀûhttp://www.google.com/patents/CN102552200A?cl=zh [0077] ¸ôÑõ¡¢±Ü¹âÊÔÑé ½«¼ÓÓÐÓÐÉ«°üÒµÄÑùÆ·£¨ÊµÊ©Àý2ÖÆ±¸µÄ²úÆ·)¡¢ËØÆ¬£¨ÊµÊ©Àý2ÖÐδ°üÒµIJúÆ·)ÔÚ 4500Ê¿500LxϽøÐйâÕÕʵÑé10Ì죬±È½Ï¶þÕßµÄÓйØÎïÖÊÇé¿ö£¬ÓÃHPLC·½·¨²â¶¨ÓйØÎïÖÊ¡£ ÓйØÎïÖʲⶨ·½·¨£º±Ü¹â²Ù×÷£¬È¡ËùÊöÑùÆ·ÊÊÁ¿£¬ÑÐϸ£¬¾«Ãܳƶ¨£¬¼ÓÒÒëæ³¬Éùʹ·ÇÂåµØÆ½ÈܽⲢ¶¨Á¿Ï¡ÊÍÖÆ³ÉÿImlÖÐÔ¼º¬·ÇÂåµØÆ½0. 5mgµÄÈÜÒº£¬Â˹ý£¬È¡ÐøÂËÒº×÷Ϊ¹©ÊÔÆ·ÈÜÒº£» ¾«ÃÜÁ¿È¡¹©ÊÔÆ·ÈÜÒºImlÖÃIOOmlÁ¿Æ¿ÖУ¬ÓÃÁ÷¶¯ÏàÏ¡ÊÍÖÁ¿Ì¶È£¬Ò¡„ò×÷Ϊ¶ÔÕÕÈÜÒº£»ÁíÈ¡·ÇÂåµØÆ½ÔÓÖÊA¶ÔÕÕÆ·£¬¾«Ãܳƶ¨£¬¼ÓÒÒëæÈܽⲢ¶¨Á¿Ï¡ÊÍÖÆ³ÉÿImlÖÐÔ¼º¬15 ¦Ì gµÄÈÜÒº£¬×÷ΪÔÓÖʶÔÕÕÈÜÒº£»ÕÕ¸ßЧҺÏàÉ«Æ×·¨£¨ÖйúÒ©µä2010Äê¶þ²¿¸½Â¼V D)ÊÔÑé¡£ÓÃÊ®°ËÍé»ù¼üºÏ¹è½ºÎªÌî³ä¼Á£»ÒÒëæ-¼×´¼-Á×ËáÑλº³åÒº£¨PH3. 0)ΪÁ÷¶¯Ïࣻ¼ì²â²¨³¤Îª238nm £» ÔÓÖÊA [Ñõ»¯²úÎH152/37)] £º4 (2£¬3-¶þÂȱ½»ù)_2£¬6-¶þ¼×»ùßÁà¤-3£¬5-¶þôÈËáÒÒ»ù¼×»ùõ¥Óë·ÇÂåµØÆ½¼°ÆäËüÔÓÖÊ·åµÄ·ÖÀë¶ÈÓ¦·ûºÏÒªÇó¡£¾«ÃÜÁ¿È¡¹©ÊÔÆ·ÈÜÒº¡¢¶ÔÕÕÈÜÒº¡¢ÔÓÖʶÔÕÕÈÜÒº¸÷20 ¦Ì 1£¬·Ö±ð×¢ÈëÒºÏàÉ«Æ×ÒÇ£¬¼Ç¼ɫÆ×ͼÖÁÖ÷·å±£Áôʱ¼äµÄ3±¶¡£ËùµÃÉ«Æ×ͼ·Ö±ðΪͼ1ºÍͼ2£¬ÔÓÖʽá¹ûÈçÏ¡£ ================== ¼´ ÔÓÖÊA [Ñõ»¯²úÎH152/37)] £º4 (2£¬3-¶þÂȱ½»ù)_2£¬6-¶þ¼×»ùßÁà¤-3£¬5-¶þôÈËáÒÒ»ù¼×»ùõ¥ ×ãÒÔÖ¤Ã÷ÍÆ²âÍêÈ«ÕýÈ·¡£ |

3Â¥2014-02-27 09:28:51














»Ø¸´´ËÂ¥